Octapharma
Highly Engaged Employees
Blood & Organ Banks · Switzerland · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Seidenstrasse 2, Lachen, Schwyz, 8853, S...Phone Number
+41 554512121Website
www.octapharma.comRevenue
$2.7 BillionIndustry
About Octapharma
Octapharma Org Chart
Is Octapharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Octapharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Octapharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Octapharma has new funding data
Click to see if Octapharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Octapharma launches new products
Octapharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Octapharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Octapharma
Recommended Actions
Reach out to Masked Content who joined Octapharma as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Octapharma is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Octapharma is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Octapharma.
Octapharma Tech Stack
A closer look at the technologies used by Octapharma
Most Recent Scoops
Octapharma News & Media
York County approves tax incentives for $1.5B Octapharma project
The York County Council unanimously approved tax incentives Monday night for a $1.5 billion project that would bring Octapharma, a Switzerland-based company, to the area.Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG
Financing will accelerate the development of proprietary portable diagnostic platform, CoagCare™, to enhance patient care for bleeding disorders & critical care medicine MENLO PARK, Calif., Feb. 25, 2026 /PRNewswire/ -- Abram Scientific, a medical device company focused on advancing...FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency
PARAMUS, N.J., Jan. 7, 2026 /PRNewswire/ -- Octapharma USA, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new 2-gram presentation of Fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in patients with...Blood Plasma Derivatives Market Set to Witness Significant Growth by 2025-2032 | Shire Plc., CSL Limited, Octapharma AG
Blood Plasma Derivatives Market is estimated to valued USD 52.96 Bn in 2025 and expected to reach USD 98.69 Bn by 2032, growing CAGR of 9.3% from 2025 to 2032 BURLINGAME, CA, UNITED STATES, September 15, 2025 /EINPresswire.com/ -- Coherent Market …
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Octapharma
Founded in 1983 and headquartered in Lachen, Switzerland, Octapharma is a manufacturer of human protein. Its core business is the development and production of human proteins from human plasma and human cell lines... Read More